Skip to main content

Table 3 Common involved sites of bone DLBCL

From: Clinical characteristics and prognostic factors of bone lymphomas: focus on the clinical significance of multifocal bone involvement by primary bone large B-cell lymphomas

Sites

uPB-DLBCL (N = 37)

mPB-DLBCL (N = 23)

SB-DLBCL (N = 23)

Extremities, n (%)

   

Femur

12(32.4)

12(52.2)

7(30.4)

Humerus

6(16.2)

5(21.7)

3(13.0)

Tibia

5(13.5)

6(26.1)

2 (8.7)

Pelvis, n (%)

5(13.5)

13(56.5)

9 (39.1)

Spine, n (%)

7(18.9)

13(56.5)

11 (47.8)

  1. Abbreviations uPB-DLBCL: primary bone diffuse large B-cell lymphoma with unifocal bone disease; mPB-DLBCL: primary bone diffuse large B-cell lymphoma with multifocal bone disease; SB-DLBCL: secondary bone diffuse large B-cell lymphoma.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us